DAP10 Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is a Src family kinase inhibitor. By targeting Src kinases, it can influence downstream signaling pathways involved in immune responses, potentially indirectly modulating DAP10 by altering cellular processes related to immune cell activation and function. | ||||||
PI-103 | 371935-74-9 | sc-203193 sc-203193A | 1 mg 5 mg | $33.00 $131.00 | 3 | |
PI-103 is a dual PI3K/mTOR inhibitor. By inhibiting both PI3K and mTOR, it can modulate signaling cascades associated with cell survival and proliferation, potentially indirectly impacting DAP10 by influencing cellular processes dependent on these pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor. By targeting mTOR, it can impact protein synthesis and cell growth, potentially indirectly modulating DAP10 levels through alterations in cellular processes dependent on the mTOR pathway, such as cell proliferation and differentiation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor affecting the PI3K/Akt signaling pathway. By inhibiting PI3K, it can modulate downstream signaling cascades, potentially indirectly influencing DAP10 levels through alterations in cellular processes regulated by the PI3K/Akt pathway, such as cell survival and growth. | ||||||
PP242 | 1092351-67-1 | sc-301606A sc-301606 | 1 mg 5 mg | $57.00 $172.00 | 8 | |
PP242 is an mTOR inhibitor. By specifically targeting mTOR, it can impact protein synthesis and cell growth, potentially indirectly modulating DAP10 levels through alterations in cellular processes dependent on the mTOR pathway, such as cell proliferation and differentiation. | ||||||
AZD8055 | 1009298-09-2 | sc-364424 sc-364424A | 10 mg 50 mg | $163.00 $352.00 | 12 | |
AZD8055 is a dual mTORC1 and mTORC2 inhibitor. By inhibiting both mTOR complexes, it can modulate signaling cascades associated with cell survival and proliferation, potentially indirectly impacting DAP10 by influencing cellular processes dependent on these pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor that disrupts the PI3K/Akt signaling pathway. By inhibiting PI3K, it can modulate downstream signaling cascades, potentially indirectly influencing DAP10 levels through alterations in cellular processes regulated by the PI3K/Akt pathway, such as cell survival and growth. | ||||||
PP 1 | 172889-26-8 | sc-203212 sc-203212A | 1 mg 5 mg | $86.00 $145.00 | 6 | |
PP1 is a Src family kinase inhibitor. By targeting Src kinases, it can influence downstream signaling pathways involved in immune responses, potentially indirectly modulating DAP10 by altering cellular processes related to immune cell activation and function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. By blocking p38 MAPK, it can modulate signaling pathways involved in inflammation and stress responses, potentially indirectly influencing DAP10 levels through alterations in cellular stress responses and immune-related processes. | ||||||
BMS-536924 | 468740-43-4 | sc-507397 | 5 mg | $285.00 | ||
BMS-536924 is a dual kinase inhibitor targeting IGF-1R and IR. By inhibiting these receptors, it can modulate signaling cascades related to cell growth and survival, potentially indirectly impacting DAP10 by influencing cellular processes dependent on IGF-1R and IR pathways. | ||||||